Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neda Dadgar

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Surgery|December 14, 2023
Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 monthsAmy L Lightner, Ana Otero Pineiro, Jane Reese, et al.
Steroids|May 19, 2021
In vitro evaluation of ferutinin on proliferation and osteogenesis differentiation in human unrestricted Somatic stem cellsZahra Mahmoudi, Abbas Saidi, Mehrdad Iranshahi, et al.
Journal of Crohn'S & Colitis|November 2, 2022
A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the PouchAmy L Lightner, Jane Reese, Justin Ream, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 29, 2022
A phase IB/IIA study of remestemcel-L, an allogeneic bone marrow-derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysisAmy L Lightner, Neda Dadgar, Caroline Matyas, et al.
Microsystems & Nanoengineering|September 27, 2021
A microfluidic platform for cultivating ovarian cancer spheroids and testing their responses to chemotherapiesNeda Dadgar, Alan M Gonzalez-Suarez, Pouria Fattahi, et al.
American Journal of Physiology. Cell Physiology|July 23, 2020
Microfluidic confinement enhances phenotype and function of hepatocyte spheroidsJong Hoon Choi, Lorena Loarca, Jose M De Hoyos-Vega, et al.
Surgery|September 4, 2023
A phase IB/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn's diseaseAmy L Lightner, Jane S Reese, Justin Ream, et al.
Cell Biology International|November 2, 2022
Mesenchymal stem cells: A novel treatment option for primary sclerosing cholangitisAmy L Lightner, Neda Dadgar, Anil Vaidya, et al.
Cancers|October 28, 2023
Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor EnvironmentCatherine R Lewis, Neda Dadgar, Samuel A Yellin, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal CarcinomatosisChristopher Sherry, Neda Dadgar, Zuqiang Liu, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Surgery|December 14, 2023
Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 monthsAmy L Lightner, Ana Otero Pineiro, Jane Reese, et al.
Steroids|May 19, 2021
In vitro evaluation of ferutinin on proliferation and osteogenesis differentiation in human unrestricted Somatic stem cellsZahra Mahmoudi, Abbas Saidi, Mehrdad Iranshahi, et al.
Journal of Crohn'S & Colitis|November 2, 2022
A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the PouchAmy L Lightner, Jane Reese, Justin Ream, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 29, 2022
A phase IB/IIA study of remestemcel-L, an allogeneic bone marrow-derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysisAmy L Lightner, Neda Dadgar, Caroline Matyas, et al.
Microsystems & Nanoengineering|September 27, 2021
A microfluidic platform for cultivating ovarian cancer spheroids and testing their responses to chemotherapiesNeda Dadgar, Alan M Gonzalez-Suarez, Pouria Fattahi, et al.
American Journal of Physiology. Cell Physiology|July 23, 2020
Microfluidic confinement enhances phenotype and function of hepatocyte spheroidsJong Hoon Choi, Lorena Loarca, Jose M De Hoyos-Vega, et al.
Surgery|September 4, 2023
A phase IB/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn's diseaseAmy L Lightner, Jane S Reese, Justin Ream, et al.
Cell Biology International|November 2, 2022
Mesenchymal stem cells: A novel treatment option for primary sclerosing cholangitisAmy L Lightner, Neda Dadgar, Anil Vaidya, et al.
Cancers|October 28, 2023
Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor EnvironmentCatherine R Lewis, Neda Dadgar, Samuel A Yellin, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal CarcinomatosisChristopher Sherry, Neda Dadgar, Zuqiang Liu, et al.
Pageof 4